Which Treatment Suits Your Weight Management Goals?
Ozempic Wegovy Mounjaro: Understanding the Key Differences
When comparing Wegovy versus Mounjaro, the fundamental difference lies in their mechanisms of action. Wegovy contains semaglutide, a GLP-1 receptor agonist that mimics your body's natural fullness hormone to reduce appetite and promote satiety after smaller meals. Mounjaro uses tirzepatide, a dual agonist targeting both GIP and GLP-1 receptors, potentially offering enhanced metabolic effects through this combined approach. Both are prescription-only medicines requiring careful clinical supervision and dose escalation protocols.
The dosing schedules also differ significantly between these treatments. Wegovy follows a 5-step escalation from 0.25mg to 2.4mg maintenance dose over 16 weeks, whilst Mounjaro offers 6 dose levels from 2.5mg up to 15mg. Neither treatment should be considered superior without individual clinical context—your prescriber will assess factors including your medical history, current medications, and treatment goals to determine the most suitable option.
Comprehensive Pricing Breakdown for Both Treatments
At EverydayMeds, we provide transparent pricing for both Wegovy and Mounjaro to help you budget effectively. Wegovy single pens range from £79.99 for the 0.25mg starter dose up to £209.99 for the 2.4mg maintenance strength. Our Getting Started bundles offer convenient dose progression—the Intro Duo (0.25mg & 0.5mg) costs £169.99, whilst the Progress Duo (0.5mg & 1mg) is priced at £189.99. New customers receive code FIRST40 at checkout, with returning customers benefiting from DOSE25.
Mounjaro pricing follows a similar structure with competitive rates across all dose strengths. Our 3-pen Take-It-Slow bundles provide extended supply options—the Gentle Start Trio costs £269.99, perfect for patients requiring slower dose escalation. The Ultimate Stability Trio offers three months of 2.4mg maintenance supply for £649.99. Both treatments qualify for our next-day cold-chain delivery service once your prescription is approved by our clinical team.
Clinical Evidence Supporting Ozempic Wegovy Mounjaro Efficacy
The STEP clinical trial programme demonstrated Wegovy's effectiveness in weight management when used alongside reduced-calorie diet and increased physical activity. In the pivotal STEP 1 trial, patients achieved approximately 15% average weight loss at 68 weeks compared to 2.4% with placebo (Wilding et al., NEJM, 2021). The SELECT cardiovascular outcomes trial showed a 20% reduction in major cardiovascular events, highlighting potential broader health benefits beyond weight management.
Mounjaro's clinical evidence comes from the SURMOUNT trial series, showing significant weight reductions in participants following the complete treatment protocol. However, directly comparing trial results between Wegovy and Mounjaro isn't clinically meaningful due to different study designs, patient populations, and endpoints. Both treatments require long-term commitment—stopping either medication typically results in gradual weight regain over 12 months.
How Wegovy Works in Your Body
Wegovy's active ingredient semaglutide functions as a GLP-1 receptor agonist, mimicking the action of glucagon-like peptide-1 that your intestines naturally produce after eating. This mechanism reduces appetite by acting on brain centres that control hunger and satiety, helping you feel fuller after smaller portions. The medication also slows gastric emptying, meaning food stays in your stomach longer, contributing to prolonged feelings of fullness. Additionally, Wegovy may reduce food cravings and the psychological drive to eat, particularly for high-calorie foods. The once-weekly injection schedule helps maintain consistent therapeutic levels, supporting sustainable weight management when combined with lifestyle modifications. This comprehensive approach addresses multiple pathways involved in appetite regulation and energy balance.
Streamlined Ordering Process for Both Treatments
Getting started with either Wegovy or Mounjaro through EverydayMeds involves a straightforward three-step process designed for convenience and safety. First, complete our 3-minute online clinical assessment covering your medical history, current medications, and weight management goals. Our qualified prescribers then review your information within standard 3 working days (or 24 hours with express service) to ensure clinical suitability. Once approved, your medication is dispatched via next-day delivery using specialist cold-chain transport to maintain temperature integrity. We're a fully registered UK pharmacy (GPhC #9012878) ensuring all treatments meet MHRA quality standards. Regular follow-up assessments monitor your progress and adjust treatment as needed for optimal results.
Storage and Practical Considerations
Storage requirements represent a key practical difference when choosing between these treatments. Wegovy pens must be stored in the fridge at 2-8°C before first use but can remain at room temperature below 30°C for up to 6 weeks once removed—offering superior travel flexibility compared to Mounjaro's 21-day room temperature limit. Both use pre-filled injection pens with different mechanisms: Wegovy uses Novo Nordisk's FlexTouch system whilst Mounjaro employs Eli Lilly's KwikPen technology. Dose escalation is mandatory for both treatments to minimise gastrointestinal side effects—you cannot skip doses or accelerate the schedule without clinical supervision. Weekly injection timing should remain consistent, though the specific day can be adjusted if needed with at least 48 hours between doses. Always follow the prescribed escalation schedule to optimise tolerance and effectiveness.
Choosing Between Ozempic Wegovy Mounjaro Options
The decision between Wegovy and Mounjaro often comes down to individual factors rather than one being universally superior. Some patients respond better to single-target GLP-1 therapy (Wegovy), whilst others may benefit from the dual-agonist approach of Mounjaro targeting both GIP and GLP-1 receptors. Your prescriber will consider your diabetes status, cardiovascular risk factors, previous weight loss attempts, and medication tolerance when making recommendations.
Cost considerations may also influence your choice, as the treatments have different pricing structures and dose escalation patterns. Storage convenience could be decisive if you travel frequently—Wegovy's longer room temperature stability provides more flexibility for business trips or holidays. Both treatments are available through EverydayMeds with identical service standards, prescription review processes, and delivery options, ensuring you receive the same high-quality care regardless of which option you choose.
Order Your Chosen Treatment Today
Both Wegovy and Mounjaro are immediately available through our secure online platform with professional clinical oversight throughout your treatment journey. New customers can apply code FIRST40 at checkout for their first order, whilst returning patients benefit from DOSE25 on subsequent purchases. Our GPhC-registered pharmacy (#9012878) ensures every prescription meets UK quality and safety standards with full regulatory compliance. Start your clinical assessment today at https://everydaymeds.co.uk/collections/weight-loss to begin your weight management journey with confidence. Remember, both treatments work best alongside reduced-calorie diet and increased physical activity as part of a comprehensive lifestyle approach to sustainable weight management.
Reviewed by the EverydayMeds Clinical Team · GPhC #9012878 · Last updated February 2026
